Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ypsomed Holding AGXSWX:YPSN -0.38%92 Return-on-Tangible-Asset is 14.57% as of Mar. 2026, which is 43% above its 10-year median of 10.21. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF396.62 (Fairly Valued). The stock has 3 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Ypsomed Holding AG ranks better than 95.91% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Ypsomed Holding AG's annualizedNet Income for the quarter that ended in Mar. 2026 was CHF165.7 Mil. Ypsomed Holding AG's average total tangible assets for the quarter that ended in Mar. 2026 was CHF1,137.2 Mil. Therefore, Ypsomed Holding AG's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 14.57%.
The historical rank and industry rank for Ypsomed Holding AG's Return-on-Tangible-Asset or its related term are showing as below:
XSWX:YPSN'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.03 Med: 10.21 Max: 20.21
Current: 20.21
During the past 13 years, Ypsomed Holding AG's highest Return-on-Tangible-Asset was 20.21%. The lowest was 1.03%. And the median was 10.21%.
XSWX:YPSN's Return-on-Tangible-Asset is ranked better than 95.91% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.595
vs XSWX:YPSN: 20.21
Ypsomed Holding AG (XSWX:YPSN) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Ypsomed Holding AG Return-on-Tangible-Asset Related Terms
Ypsomed Holding AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Ypsomed Holding AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:YPSN vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ypsomed Holding AG Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Ypsomed Holding AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 14.57% mean?
Ypsomed Holding AG (XSWX:YPSN) has a Return-on-Tangible-Asset of 14.57% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Ypsomed Holding AG and its competitors. This is 43% above median its historical median of 10.21. Over the past decade, Ypsomed Holding AG's Return-on-Tangible-Asset has ranged from 1.03 to 20.21. According to the industry distribution chart, Ypsomed Holding AG ranks #35 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 4.1%.
Is Ypsomed Holding AG's Return-on-Tangible-Asset too high?
Ypsomed Holding AG's current Return-on-Tangible-Asset of 14.57% is 43% above median its 10-year median of 10.21. Over the past 10 years, this metric has ranged from a low of 1.03 to a high of 20.21. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.60. Ypsomed Holding AG's value of 14.57% is 2348.7% above this industry median. Based on the distribution chart, Ypsomed Holding AG ranks #35 out of 856 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ypsomed Holding AG ranks #35 out of 856 companies for Return-on-Tangible-Asset. This places Ypsomed Holding AG in the top 4% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.60. Ypsomed Holding AG's value of 14.57% is 2348.7% above this benchmark. Historically, Ypsomed Holding AG's own Return-on-Tangible-Asset has ranged from 1.03 to 20.21 over the past decade. While the company's 10-year median is 10.21 vs. the industry median of 0.60, Ypsomed Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.60, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ypsomed Holding AG's current Return-on-Tangible-Asset of 14.57% is 2348.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Ypsomed Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ypsomed Holding AG's current Return-on-Tangible-Asset is 14.57%, which is 43% above median its own 10-year median of 10.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF396.62, compared to a current price of CHF366.60 — trading 7.6% below its estimated fair value. The current Return-on-Tangible-Asset is 14.57%, which is 43% above median its 10-year median of 10.21 and 2348.7% above the Medical Devices & Instruments industry median of 0.60. Ypsomed Holding AG's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Return-on-Tangible-Asset is 14.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?
Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued.
The current stock price of CHF366.60 is trading 7.6% below its estimated GF Value™ of CHF396.62.
GuruFocus considers Ypsomed Holding AG to be Fairly Valued.
Key valuation signals for XSWX:YPSN:
Return-on-Tangible-Asset: 14.57% (43% above median its 10-year median of 10.21)
GF Value™: CHF396.62 vs. price of CHF366.60 (7.6% below fair value)
Industry Position: 2348.7% above the Medical Devices & Instruments median (#35 of 856)
No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score
Get the complete analysis for XSWX:YPSN
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:YPSN has been successfully added to your 
